neuropathic pain

Red stop sign on road
Biotech

Eli Lilly sidelines pain prospect in another pipeline shift

The asset was originally licensed from Asahi Kasei Pharma in 2021, and Lilly is now exploring other possible indications for the P2X7 inhibitor.
Darren Incorvaia Oct 30, 2025 2:19pm
Closeup of blue eye on black background

Okyo's eye drops reduce neuropathic eye pain in phase 2 win

Jul 16, 2025 11:57am
pain management pain

Lexicon feels the pain as non-opioid data underwhelm investors

Mar 3, 2025 9:52am
pain management pain

Vertex passes neuropathic pain test, teeing up pivotal trials

Dec 13, 2023 7:52am
An artists concept of spinal pain A silhouette of a person stands holding their back The spinal cord is highlighted on the

Gene therapy reduces chronic pain and chemo-induced neuropathy

Jul 31, 2023 9:30am
Graphic of employees walking out depicting layoffs

Sangamo lays off 27% of US staff in latest refocus

Apr 27, 2023 8:55am